The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 39 | — | 20.1x | Near average | |
Growth | 4 | -83.2% | 5.6% | Below average | |
Quality | 38 | -99.6% | 7.6% | Near average | |
Safety | 58 | 0.5x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | 56 | — | — | Near average | |
Sentiment | 23 | — | — | Below average |
Stoke Therapeutics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Stoke Therapeutics, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
STOK stock has seen a significant increase in analyst coverage recently, with the number of analysts participating in the consensus rising from 3 to 7, while the average price target stabilized at 43.86 dollars. This stability, despite the increased number of opinions, reflects growing confidence in the stock's fair value, especially with a significant positive gap between the current price (29.96 dollars) and the lowest observed price target (35 dollars), indicating collective optimism for growth.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.